NCT00766142 Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00749450 Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00721513 Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT00720512 Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab Status TERMINATED Phase PHASE3
NCT00719797 Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00711243 Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor Status COMPLETED Phase PHASE1/PHASE2
NCT00707889 Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00707473 Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT00665392 Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer Status COMPLETED Phase PHASE2
NCT00654160 Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer Status COMPLETED Phase PHASE1
NCT00647530 Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery Status UNKNOWN Phase PHASE2/PHASE3
NCT00646659 Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery Status TERMINATED Phase PHASE2
NCT00642746 Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC) Status TERMINATED Phase PHASE2
NCT00642577 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE3
NCT00640081 Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00630032 Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer Status COMPLETED Phase PHASE3
NCT00629863 Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer Status COMPLETED Phase NA
NCT00629278 Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer Status UNKNOWN Phase PHASE3
NCT00628810 Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00625092 Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies Status COMPLETED Phase PHASE1